These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 36927383)
1. The role of the desmosomal protein desmocollin 2 in tumour progression in triple negative breast cancer patients. Reimer F; Bryan S; Legler K; Karn T; Eppenberger-Castori S; Matschke J; Pereira-Veiga T; Wikman H; Witzel I; Müller V; Schmalfeldt B; Milde-Langosch K; Schumacher U; Stürken C; Oliveira-Ferrer L Cancer Cell Int; 2023 Mar; 23(1):47. PubMed ID: 36927383 [TBL] [Abstract][Full Text] [Related]
2. Androgen downregulates desmocollin-2 in association with induction of mesenchymal transition of breast MDA-MB-453 cancer cells. Ahram M; Abdullah MS; Mustafa SA; Alsafadi DB; Battah AH Cytoskeleton (Hoboken); 2021 Aug; 78(8):391-399. PubMed ID: 35023302 [TBL] [Abstract][Full Text] [Related]
3. Desmoglein 2 and desmocollin 2 depletions promote malignancy through distinct mechanisms in triple-negative and luminal breast cancer. Han JY; Che N; Mo J; Zhang DF; Liang XH; Dong XY; Zhao XL; Sun BC BMC Cancer; 2024 Apr; 24(1):532. PubMed ID: 38671389 [TBL] [Abstract][Full Text] [Related]
4. Desmosomal proteins of DSC2 and PKP1 promote cancer cells survival and metastasis by increasing cluster formation in circulatory system. Li K; Wu R; Zhou M; Tong H; Luo KQ Sci Adv; 2021 Oct; 7(40):eabg7265. PubMed ID: 34586853 [TBL] [Abstract][Full Text] [Related]
5. FGF13 promotes metastasis of triple-negative breast cancer. Johnstone CN; Pattison AD; Harrison PF; Powell DR; Lock P; Ernst M; Anderson RL; Beilharz TH Int J Cancer; 2020 Jul; 147(1):230-243. PubMed ID: 31957002 [TBL] [Abstract][Full Text] [Related]
6. Protein Tyrosine Kinase 7 Regulates EGFR/Akt Signaling Pathway and Correlates With Malignant Progression in Triple-Negative Breast Cancer. Cui NP; Qiao S; Jiang S; Hu JL; Wang TT; Liu WW; Qin Y; Wang YN; Zheng LS; Zhang JC; Ma YP; Chen BP; Shi JH Front Oncol; 2021; 11():699889. PubMed ID: 34367983 [TBL] [Abstract][Full Text] [Related]
7. Down-regulated desmocollin-2 promotes cell aggressiveness through redistributing adherens junctions and activating beta-catenin signalling in oesophageal squamous cell carcinoma. Fang WK; Liao LD; Li LY; Xie YM; Xu XE; Zhao WJ; Wu JY; Zhu MX; Wu ZY; Du ZP; Wu BL; Xie D; Guo MZ; Xu LY; Li EM J Pathol; 2013 Oct; 231(2):257-70. PubMed ID: 23836524 [TBL] [Abstract][Full Text] [Related]
8. Context-dependent roles of MDMX (MDM4) and MDM2 in breast cancer proliferation and circulating tumor cells. Gao C; Xiao G; Piersigilli A; Gou J; Ogunwobi O; Bargonetti J Breast Cancer Res; 2019 Jan; 21(1):5. PubMed ID: 30642351 [TBL] [Abstract][Full Text] [Related]
9. Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways. Singel SM; Batten K; Cornelius C; Jia G; Fasciani G; Barron SL; Wright WE; Shay JW Breast Cancer Res; 2014 Mar; 16(2):R28. PubMed ID: 24642040 [TBL] [Abstract][Full Text] [Related]
10. Endocan as a prognostic biomarker of triple-negative breast cancer. Sagara A; Igarashi K; Otsuka M; Kodama A; Yamashita M; Sugiura R; Karasawa T; Arakawa K; Narita M; Kuzumaki N; Narita M; Kato Y Breast Cancer Res Treat; 2017 Jan; 161(2):269-278. PubMed ID: 27888420 [TBL] [Abstract][Full Text] [Related]
11. Using an in-vivo syngeneic spontaneous metastasis model identifies ID2 as a promoter of breast cancer colonisation in the brain. Kijewska M; Viski C; Turrell F; Fitzpatrick A; van Weverwijk A; Gao Q; Iravani M; Isacke CM Breast Cancer Res; 2019 Jan; 21(1):4. PubMed ID: 30642388 [TBL] [Abstract][Full Text] [Related]
12. COL8A1 enhances the invasion/metastasis in MDA-MB-231 cells via the induction of IL1B and MMP1 expression. Sagara A; Miura S; Kobinata A; Naganawa R; Yaginuma S; Saito S; Saito R; Kominato H; Yumoto T; Sato F Biochem Biophys Res Commun; 2023 Jan; 642():145-153. PubMed ID: 36577251 [TBL] [Abstract][Full Text] [Related]
13. Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat. Tate CR; Rhodes LV; Segar HC; Driver JL; Pounder FN; Burow ME; Collins-Burow BM Breast Cancer Res; 2012 May; 14(3):R79. PubMed ID: 22613095 [TBL] [Abstract][Full Text] [Related]
14. A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer. Sambi M; Samuel V; Qorri B; Haq S; Burov SV; Markvicheva E; Harless W; Szewczuk MR Drug Des Devel Ther; 2020; 14():1995-2019. PubMed ID: 32546966 [TBL] [Abstract][Full Text] [Related]
15. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448. Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489 [TBL] [Abstract][Full Text] [Related]
16. Antisense expression of a desmocollin gene in MDCK cells alters desmosome plaque assembly but does not affect desmoglein expression. Roberts GA; Burdett ID; Pidsley SC; King IA; Magee AI; Buxton RS Eur J Cell Biol; 1998 Jul; 76(3):192-203. PubMed ID: 9716266 [TBL] [Abstract][Full Text] [Related]
17. Genomic insights into triple-negative and HER2-positive breast cancers using isogenic model systems. Mudvari P; Ohshiro K; Nair V; Horvath A; Kumar R PLoS One; 2013; 8(9):e74993. PubMed ID: 24086418 [TBL] [Abstract][Full Text] [Related]
18. Exosomal MMP-1 transfers metastasis potential in triple-negative breast cancer through PAR1-mediated EMT. Zhu Y; Tao Z; Chen Y; Lin S; Zhu M; Ji W; Liu X; Li T; Hu X Breast Cancer Res Treat; 2022 May; 193(1):65-81. PubMed ID: 35254603 [TBL] [Abstract][Full Text] [Related]